Alert

Recommended Alerts

Sign Up For Alerts

CMS Issues Final Rule Redefining Medicare Part D “Negotiated Price” As Pharmacy’s Lowest Possible Reimbursement

On April 29, 2022, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule revising the way Medicare determines the “negotiated price” (i.e., the price upon which beneficiary cost-sharing is based at the pharmacy counter) under Medicare Part D.

Read More

Supreme Court Rejects Bright-Line Test For Materiality in Rule 10b-5 Class Action With Respect to Adverse Event Reports

Practices: Life Sciences, Corporate & Securities Litigation, Securities & Public Companies Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings